文献速递心力衰竭与心肌病心律失常

扩张型心肌病的性别差异:证据缺口与未来方向

Sex Differences in Dilated Cardiomyopathy: Evidence Gaps and Future Directions.
PubMed 文献 · J Am Coll Cardiol · 2025-11-26

该综述探讨性别对扩张型心肌病(DCM)在流行病学、病因、临床表现、治疗反应和结局方面的影响,并通过系统综述与荟萃分析发现不同基因变异携带者的心律失常和心衰风险存在性别差异,指出当前风险分层工具可能因采用性别中性阈值而导致女性治疗不足,呼吁扩大女性在DCM研究中的代表性并开发性别特异性风险模型。

要点

  • 女性DCM患者常表现为较轻的心脏表型,包括较低纤维化水平和较好左心室功能。
  • PLN、DSP和LMNA变异男性DCM患者心律失常事件率高于TTNtv和BAG3携带者。
  • 女性DCM患者中RBM20、DSP和PLN变异心律失常风险最高,TTNtv携带者最低。

核心结论

  • 性别与基因型共同影响DCM临床结局,当前风险分层工具可能致女性治疗不足,需开发性别特异性风险模型。

研究设计与样本

  • 综述结合系统综述与荟萃分析,探讨性别对DCM流行病学、病因、临床表现、治疗反应和结局的影响。

主要发现

  • 男性DCM患者中PLN、DSP和LMNA变异携带者心律失常事件率高于TTNtv和BAG3携带者。
  • 女性DCM患者中RBM20、DSP和PLN变异携带者心律失常风险最高,TTNtv携带者最低。
  • PLN和LMNA变异在男女两性中均与最高心衰风险相关。
  • 女性BAG3、RBM20和TTN变异携带者心衰发生率低于男性携带者。
  • 女性DCM患者常表现为较低纤维化水平和较好左心室功能,但长期预后不明确。

关键数值与推荐

  • DCM影响1/250人群,是全球心衰leading cause和最常见心脏移植指征。
  • 当前ICD等风险分层工具依赖性别中性阈值,可能致女性治疗不足。

临床怎么用

  • 临床应关注DCM的性别特异性表现和基因型相关风险差异。
  • 评估ICD指征时需考虑女性可能因性别中性阈值而被低估风险。
  • 需关注妊娠、妊娠并发症和绝经等生殖因素对DCM性别差异的影响。

局限性

  • 女性在DCM研究中代表性不足,证据存在缺口。
  • 女性DCM长期预后尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dilated cardiomyopathy (DCM), which affects 1 in 250 people, is a leading global cause of heart failure and the most common indication for heart transplantation. Evidence suggests that DCM is more prevalent in men, but whether this reflects biological differences or underdiagnosis in women remains uncertain. This review explores the impact of sex on DCM, examining differences in epidemiology, etiology, clinical presentation, treatment response, and outcomes. Women often present with less severe cardiac phenotypes, including lower levels of fibrosis and better left ventricular function, yet the long-term prognosis of DCM in women is less clear. Through a systematic review and meta-analysis, we found that male DCM patients with variants in PLN, DSP, and LMNA had higher arrhythmic event rates compared with TTNtv and BAG3 carriers. In female patients with DCM, those with RBM20, DSP, and PLN variants faced the highest arrhythmic risk, and TTNtv carriers the lowest. PLN and LMNA variants had the highest heart failure risk in both sexes, whereas BAG3, RBM20, and TTN variants had lower heart failure rates in female compared with male carriers. These findings highlight the influence of sex and genotype on clinical outcomes. Current risk-stratification tools, such as those used for implantable cardioverter-defibrillators, may undertreat women owing to reliance on sex-neutral thresholds. We highlight the role of genetic, environmental, and reproductive factors in shaping these disparities, including the influence of pregnancy, pregnancy complications, and menopause. This review identifies key gaps in knowledge and calls for expanded representation of women in DCM studies and the development of sex-specific risk models. Addressing these gaps is essential to improving outcomes and advancing equitable personalized care for all DCM patients.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Stroeks SLVM, Oko-Osi S, Arasu A, et al. Sex Differences in Dilated Cardiomyopathy: Evidence Gaps and Future Directions. J Am Coll Cardiol. 2025. PMID: 41295940. doi:10.1016/j.jacc.2025.09.1603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。